financetom
Business
financetom
/
Business
/
Gold Reserve Says Not Selected in Citgo Petroleum Sale Process; Shares Jumped 23.6% Last Friday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gold Reserve Says Not Selected in Citgo Petroleum Sale Process; Shares Jumped 23.6% Last Friday
Sep 2, 2025 4:48 AM

07:22 AM EDT, 09/02/2025 (MT Newswires) -- Gold Reserve ( GDRZF ) , which jumped 23.6% in Canada trading last Friday, said over the holiday weekend that its subsidiary, Dalinar Energy, was not selected to acquire the shares of PDV Holding (PDVH), parent company of U.S.-based Citgo Petroleum.

Amber Energy, which is backed by a group of strategic U.S. energy investors, and which offered $5.9 billion, was named in the Updated Final Recommendation.

Gold Reserve ( GDRZF ) intends to object to the decision, as Amber Energy's bid is lower than Dalinar's revised $7.9 billion price.

Objections are required to be filed on Sept. 6, and will be considered by the Court at the Sale Hearing scheduled to commence Sept. 15, a statement said.

In a separate announcement, Gold Reserve ( GDRZF ) said that on Aug. 29, the U.S. Government filed a Statement of Interest in the pending New York federal court litigation regarding the validity of the 2020 PDVSA bonds, issued by the Venezuelan state oil company.

The key question in the litigation is whether the 2020 PDVSA bonds are invalid under Venezuelan law and, if so, the consequences of this invalidity, a statement said.

Gold Reserve ( GDRZF ) closed $0.68, to $3.56, on the TSX Venture Exchange on Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RedCloud Prices $20 Million IPO
RedCloud Prices $20 Million IPO
Mar 21, 2025
04:45 AM EDT, 03/21/2025 (MT Newswires) -- RedCloud Holdings ( RCT ) said Thursday it priced its initial public offering of about 4.4 million ordinary shares at $4.50 per share, for expected gross proceeds of $20 million. IPO underwriters have a 30-day option to buy up to an additional 666,666 shares. The offering is expected to close Monday. The shares...
Toronto-Dominion Bank to Redeem 3.105% Notes in April
Toronto-Dominion Bank to Redeem 3.105% Notes in April
Mar 21, 2025
05:24 AM EDT, 03/21/2025 (MT Newswires) -- Toronto-Dominion Bank ( MLWIQXX ) said late Thursday it plans to exercise its right to redeem all of its outstanding 3 billion Canadian dollars ($2.09 billion) 3.105% notes due April 22, 2030, on April 22, 2025. The company will redeem the notes at a price of 100% of principal amount, plus applicable interest....
Novartis Gets FDA Clearance for First Approved Treatment For Rare Kidney Disease
Novartis Gets FDA Clearance for First Approved Treatment For Rare Kidney Disease
Mar 21, 2025
05:07 AM EDT, 03/21/2025 (MT Newswires) -- Novartis ( NVS ) said Thursday the US Food and Drug Administration has approved Fabhalta to treat adults with C3 glomerulopathy, the first therapy cleared for the condition. The oral drug is designed to reduce protein in urine and targets a part of the immune system thought to drive the disease, the company...
Johnson & Johnson's Tremfya Receives US FDA Approval for Crohn's Disease
Johnson & Johnson's Tremfya Receives US FDA Approval for Crohn's Disease
Mar 21, 2025
05:21 AM EDT, 03/21/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Thursday that the US Food and Drug Administration has approved its drug Tremfya for the treatment of adults with moderately to severely active Crohn's disease, a chronic inflammatory gastrointestinal tract condition. The approval follows results from a 1,300-patient phase 3 trial showing Tremfya was superior to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved